Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Biotechnology
UK biotech companies are on track for a record-breaking year of fundraising according to the latest data released by the UK BioIndustry Association (BIA) and Clarivate. 30 March 2021
Biotechnology
Life sciences investment trust Syncona has invested $42.3 million UK-based Gyroscope Therapeutics, a clinical-stage gene therapy company focused on diseases of the eye, in an $148.0 million (£107.8 million) Series C financing. 26 March 2021
Biotechnology
Abu Dhabi’s Mubadala Investment Company is to invest £800 million ($1.1 billion), alongside £200 million from the British government, in UK life sciences as part of a partnership announced on Thursday. 24 March 2021
Pharmaceutical
There has never been a better time to raise money for companies in the life sciences sector, according to Ben Long, partner at UK-headquartered private equity firm Inflexion. 23 March 2021
Biotechnology
UK-based Vaccitech said today it has raised $168 million in a Series B financing. This includes $43 million in convertible loan notes previously issued by Vaccitech that converted into Series B shares. 17 March 2021
Biotechnology
Cell and gene therapy incubator ElevateBio has raised $525 million in a Series C financing. 15 March 2021
Biotechnology
Belgium’s AgomAb Therapeutics says it has closed a $74 million Series B financing round led by Redmile Group, which will further advance its lead compound AGMB-101. 10 March 2021
Biotechnology
San Diego, USA-based Janux Therapeutics announced the close of a $56 million Series A financing round supported by top-tier investors including Avalon Ventures, OrbiMed, and RA Capital Management. The funds will help Janux advance its pre-clinical pipeline of T-cell engager immunotherapies, with a target of reaching clinical trials next year. 4 March 2021
Biotechnology
CNS specialist atai Life Sciences has announced the successful closing of its $157 million Series D financing. 3 March 2021
Biotechnology
Argobio, a newly-created start-up studio dedicated to life sciences, today announced its launch with 50 million euros ($60.3 million) of committed capital. 3 March 2021
Biotechnology
Chinese biotech Clover Biopharmaceutical has raised nearly a quarter of a billion dollars in a series C financing round, bringing the total amount raised in the last 12 months to $400 million. 25 February 2021
Pharmaceutical
Notable research news last week included Swiss pharma giant Roche releasing new Phase III data on its diabetic macular degeneration (DME) candidate faricimab. On the disappointing side, bluebird bio reported that its rare diseases therapies LentiGlobin and Zynteglo have been connected to a case of acute myeloid leukemia (AML). On the deal-making front, Nektar Therapies had a busy day last Thursday, when it announced a research financing deal with SFJ Pharma on its bempegaldesleukin and also a research collaboration with Merck & Co. Elsewhere, Astellas and Seagen have filed for US Food and Drug Administration approval for their metastatic urothelial cancer drug Padcev. 21 February 2021
Biotechnology
Nektar Therapeutics’ shares closed up 13.4% at $25.46 yesterday, after the US clinical-stage biopharma company revealed it had signed two collaboration deals. 18 February 2021
Biotechnology
Oxford University, UK, biotech spinout Evox Therapeutics today announced that it has raised £69.2 million ($95.4 million) in a Series C financing round. 18 February 2021
Biotechnology
France-based biotech OSE Immunotherapeutics today announced that the company has signed a loan agreement of up to 25 million euros ($30 million) with the European Investment Bank (EIB). 15 February 2021
Biotechnology
In Boston, USA, a new genomic medicine company called Ensoma has launched with a $70 million series A financing led by co-founder and seed investor 5AM Ventures. 11 February 2021
Biotechnology
London, UK-based cell therapy specialist Quell Therapeutics today announced the closing of an extended Series A financing led by its existing investors Syncona, which has committed an additional $34.7 million and UCL Technology Fund (UCLTF), which has committed an additional $1 million; bringing the total Series A financing to circa $84 million. 11 February 2021
Biotechnology
UK Bioindustry Association (BIA) chief executive Steve Bates yesterday released an update on the biotech sector, including on investment and COVID-19 developments. 9 February 2021
Biotechnology
A newly-formed Netherlands-based immuno-oncology company, Pan Cancer T, has closed a period of seed funding and has commenced operations at its headquarters in Rotterdam. 8 February 2021
Biotechnology
Life sciences investment group Abingworth has announced the final closing of its latest transatlantic venture fund, Abingworth Bioventures 8 (ABV 8) at $465 million. 3 February 2021
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze